At COAT Systems, we recognize the paramount significance of maintaining cleanliness and sterility within pharmaceutical and biotechnology facilities, particularly concerning the selection of appropriate pharmaceutical biotechnology flooring solutions. We understand that these specialized environments demand a heightened level of hygiene to ensure the integrity of production processes and the safety of products.

In pharmaceutical and biotechnology settings, where precision and quality are imperative, the choice of flooring plays a pivotal role. Our company comprehends the critical nature of preventing contamination, microbial growth, and cross-contamination. We acknowledge that conventional flooring materials might not suffice in meeting the stringent requirements of these industries.

COAT Systems is committed to providing advanced pharmaceutical biotechnology flooring solutions that align with the uncompromising hygiene standards of pharmaceutical and biotechnology sectors. Our flooring options are designed to resist the accumulation of dust, particles and pathogens. They are formulated to withstand rigorous cleaning procedures, including sterilization protocols, without compromising their structural integrity.

Our dedication to excellence is mirrored in our flooring products, which are meticulously crafted to be non-porous, seamless and resistant to chemicals and aggressive cleaning agents. This ensures that no hidden crevices or vulnerabilities exist where contaminants could thrive. Our understanding of the unique challenges posed by these industries allows us to deliver pharmaceutical biotechnology flooring solutions that contribute to a controlled and aseptic environment.

COAT Systems comprehends and values the utmost importance of cleanliness and sterility within pharmaceutical and biotechnology facilities. Our purpose is to offer pharmaceutical biotechnology flooring solutions that not only meet but exceed the stringent requirements of these industries, supporting their mission to produce safe and efficacious products while upholding the highest standards of hygiene.

• Seamless and non-porous surface: Epoxy pharmaceutical biotechnology flooring solutions are applied as a seamless and non-porous coating. This eliminates joints, seams and crevices where contaminants could accumulate, making it easier to clean and preventing microbial growth.
• Hygienic coating: Epoxy coatings provide a hygienic and smooth surface that resists the growth of bacteria and other microorganisms. This helps in maintaining a sterile environment.
• Chemical resistance: Epoxy is highly resistant to chemicals used in cleaning and disinfection processes. This enables frequent and rigorous cleaning without damaging the flooring or compromising its sterility.
• Easy cleaning: The non-absorbent and smooth surface of epoxy pharmaceutical biotechnology flooring solutions allows for thorough and effective cleaning using sterilizing agents, steam or other cleaning methods.

Hygiene compliance: Our epoxy pharmaceutical biotechnology flooring solutions can be formulated to comply with hygiene regulations, such as cGMP and FDA requirements, ensuring that the facility maintains the highest quality standards.

• Seamless and smooth finish: Our urethane flooring systems offer a seamless and smooth finish, similar to epoxy, which eliminates joints and seams that could harbor contaminants.
• Non-porous surface: Urethane flooring solutions provide a non-porous surface that prevents the absorption of liquids, ensuring that no contaminants or spills can infiltrate the flooring.
• Chemical resistance: Like epoxy, urethane pharmaceutical biotechnology flooring solutions are resistant to a wide range of chemicals, allowing for frequent cleaning and disinfection without compromising the floor’s integrity.
• Microbial control: The smooth, non-porous nature of urethane flooring solutions make them difficult for microorganisms to adhere and proliferate, contributing to a more sterile environment.
• Durability and longevity: COAT Systems urethane pharmaceutical biotechnology flooring solutions’ durability means that it will withstand cleaning processes over time without degrading or losing its antimicrobial properties.
• Low particle shedding: Our urethane flooring is less likely to shed particles, which is crucial in environments where even the smallest particles can lead to contamination.

Both our COAT Systems epoxy and urethane pharmaceutical biotechnology flooring solutions provide aseptic environments with the necessary features to prevent contamination of sensitive products in pharmaceutical and biotechnology facilities. Their seamless, non-porous and chemical-resistant properties create a foundation for cleanliness, sterility and compliance with rigorous industry standards. When selecting between epoxy and urethane, our COAT Systems experts can assist facility managers in assessing factors such as the specific processes, cleaning protocols and maintenance requirements to determine which option best aligns with their facility’s needs.